Clinical Trial Update: Empagliflozin in Acute Heart Failure [Phase 4]

View source ↗

Summary

This notice reports completion of a Phase 4 clinical trial evaluating empagliflozin in patients with acute heart failure, including those with chronic kidney di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Acute Heart Failure, Chronic Kidney Diseases | Phase 4 | Status: COMPLETED